Standard Biotools Inc (LAB)

May 30, 2025, 7:00 AM EDT - 7 days ago

Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series

May 6, 2025, 8:08 PM EDT - 4 weeks ago

Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript

May 6, 2025, 4:01 PM EDT - 4 weeks ago

Standard BioTools Reports First Quarter 2025 Financial Results

Apr 24, 2025, 7:00 AM EDT - 6 weeks ago

Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025

Apr 22, 2025, 7:00 AM EDT - 6 weeks ago

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

Feb 27, 2025, 4:01 PM EST - 3 months ago

Standard BioTools to Participate in Upcoming Investor Conferences

Feb 26, 2025, 9:44 PM EST - 3 months ago

Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:01 PM EST - 3 months ago

Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 12, 2025, 7:00 AM EST - 4 months ago

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

Jan 13, 2025, 7:00 AM EST - 5 months ago

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 19, 2024, 8:00 AM EST - 6 months ago

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 7, 2024, 8:00 AM EST - 7 months ago

Standard BioTools Appoints Alex Kim as Chief Financial Officer

Oct 30, 2024, 7:10 PM EDT - 7 months ago

Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:01 PM EDT - 7 months ago

Standard BioTools Reports Third Quarter 2024 Financial Results

Oct 16, 2024, 8:00 AM EDT - 8 months ago

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

Aug 28, 2024, 8:58 AM EDT - 10 months ago

Standard BioTools And 2 Other Penny Stocks Executives Are Buying

Aug 27, 2024, 9:15 AM EDT - 10 months ago

Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying

Jul 31, 2024, 8:34 PM EDT - 11 months ago

Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:02 PM EDT - 11 months ago

Standard BioTools Announces Senior Leadership Changes

Jul 31, 2024, 4:01 PM EDT - 11 months ago

Standard BioTools Reports Second Quarter 2024 Financial Results

Jul 17, 2024, 8:01 AM EDT - 11 months ago

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

May 28, 2024, 4:01 PM EDT - 1 year ago

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO CTKB DHR MASS OMIC QGEN

May 20, 2024, 8:00 AM EDT - 1 year ago

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 11, 2024, 12:45 PM EDT - 1 year ago

Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

Standard BioTools Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:01 AM EDT - 1 year ago

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Apr 8, 2024, 8:00 AM EDT - 1 year ago

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

Apr 3, 2024, 4:01 PM EDT - 1 year ago

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

Mar 18, 2024, 8:12 AM EDT - 1 year ago

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

Feb 28, 2024, 8:44 PM EST - 1 year ago

Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:01 PM EST - 1 year ago

Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 14, 2024, 8:30 AM EST - 1 year ago

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Feb 7, 2024, 8:30 AM EST - 1 year ago

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine

Jan 8, 2024, 8:30 AM EST - 1 year ago

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

Jan 5, 2024, 8:46 AM EST - 1 year ago

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

Jan 4, 2024, 10:23 PM EST - 1 year ago

Standard BioTools Stockholders Approve Merger with SomaLogic

Jan 4, 2024, 9:44 PM EST - 1 year ago

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

Dec 31, 2023, 2:10 PM EST - 1 year ago

Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Dec 29, 2023, 7:10 PM EST - 1 year ago

Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures

Dec 29, 2023, 5:04 PM EST - 1 year ago

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

Dec 28, 2023, 4:16 PM EST - 1 year ago

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools

Dec 22, 2023, 8:11 PM EST - 1 year ago

Tikvah Management Announces Intention to Vote against Somalogic's Proposed Merger with Standard BioTools

Dec 22, 2023, 8:00 PM EST - 1 year ago

Madryn Asset Management Reiterates Alternative Path to SomaLogic's Value-Destructive Proposed Merger with Standard BioTools

Dec 22, 2023, 6:57 PM EST - 1 year ago

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

Dec 22, 2023, 8:30 AM EST - 1 year ago

Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools

Dec 20, 2023, 9:00 AM EST - 1 year ago

Skye Fund III Issues Letter Regarding Opposition to SomaLogic's Proposed Merger with Standard BioTools

Dec 18, 2023, 5:36 PM EST - 1 year ago

Madryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioTools

Dec 12, 2023, 5:31 PM EST - 1 year ago

Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company's Proposed Merger with Standard BioTools

Dec 5, 2023, 5:30 PM EST - 1 year ago

STANDARD BIOTOOLS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Standard BioTools Inc. - LAB